CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new antiviral drugs by identifying compounds that inhibit viroporins, which are essential for the life cycle of RNA viruses. By utilizing a high-throughput screening platform, the project aims to enhance pandemic preparedness through the discovery of effective viroporin blockers.
The potential for future viral pandemics to trigger a global crisis underscores the urgent need for the development of new antiviral drugs.
Viroporins, identified in several RNA virus families, form pores/ion channels in cell and/or virus membranes, contributing to the virus life cycle and virus-induced pathology.
Blocking viroporins with small-molecule compounds has proven to be an effective therapeutic strategy.
However, the clinical success of these viroporin blockers has been limited due to…
KOBENHAVNS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.